Revenue
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Emergent BioSolutions Inc. (EBS)
Price$6.23Cached quote
Net income
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $742.9M | $1.04B | $1.05B | $1.12B | $1.77B | $1.56B | $1.11B | $782.4M | $560.9M | $488.8M | $522.8M | $450.1M | $312.7M | $281.9M | $273.4M | $286.2M | $234.8M |
| Gross profit | $416.7M | $362.3M | $317.6M | $383.0M | $891.3M | $925.2M | $672.5M | $460.1M | $373.2M | $362.5M | $415.3M | $348.2M | $250.6M | $235.8M | $231.2M | $239.1M | $188.5M |
| Gross margin | 56.09% | 34.72% | 30.27% | 34.27% | 50.25% | 59.48% | 60.80% | 58.81% | 66.54% | 74.16% | 79.44% | 77.35% | 80.13% | 83.65% | 84.57% | 83.54% | 80.30% |
| Research & development | $53.2M | $70.7M | $111.4M | $188.3M | $235.2M | $237.9M | $226.2M | $142.8M | $97.4M | $106.9M | $119.2M | $104.7M | $119.9M | $120.2M | $124.8M | $89.3M | $74.6M |
| Operating expenses | $642.8M | $1.15B | $1.78B | $1.29B | $1.43B | $1.14B | $991.9M | $692.6M | $436.6M | $383.3M | $273.8M | $259.0M | $207.8M | $205.8M | $199.1M | $165.5M | $148.4M |
| Operating income | $100.1M | −$108.7M | −$726.4M | −$170.0M | $341.4M | $438.5M | $114.1M | $89.8M | $124.3M | $105.5M | $141.5M | $89.2M | $42.8M | $30.0M | $32.1M | $73.6M | $40.1M |
| Operating margin | 13.47% | −10.42% | −69.23% | −15.21% | 19.25% | 28.19% | 10.32% | 11.48% | 22.16% | 21.58% | 27.07% | 19.81% | 13.69% | 10.63% | 11.74% | 25.70% | 17.10% |
| EBITDA | $195.9M | $100,000 | −$601.3M | −$26.7M | $465.2M | $488.6M | $163.6M | $126.1M | $156.5M | $133.5M | $165.3M | $111.5M | $59.8M | $41.2M | $41.5M | $79.5M | $45.1M |
| EBITDA margin | 26.37% | 0.01% | −57.30% | −2.39% | 26.23% | 31.41% | 14.79% | 16.12% | 27.90% | 27.32% | 31.61% | 24.78% | 19.12% | 14.60% | 15.16% | 27.80% | 19.23% |
| Net income | $52.6M | −$190.6M | −$760.5M | −$211.6M | $219.5M | $305.8M | $54.5M | $62.7M | $82.6M | $51.8M | $62.9M | $36.7M | $31.1M | $23.5M | $23.0M | $51.7M | $31.1M |
| Net profit margin | 7.08% | −18.26% | −72.48% | −18.94% | 12.38% | 19.66% | 4.93% | 8.01% | 14.73% | 10.60% | 12.03% | 8.16% | 9.96% | 8.35% | 8.42% | 18.07% | 13.26% |
| Basic EPSper basic share | $0.98 | -$3.60 | -$14.85 | -$4.22 | $4.10 | $5.80 | $1.06 | $1.25 | $1.98 | $1.29 | $1.63 | $0.98 | $0.86 | $0.65 | $0.65 | $1.63 | $1.02 |
| Diluted EPSper diluted share | $0.93 | -$3.60 | -$14.85 | -$4.22 | $4.06 | $5.68 | $1.04 | $1.22 | $1.71 | $1.13 | $1.41 | $0.88 | $0.85 | $0.65 | $0.64 | $1.59 | $0.99 |
Owners
Reported shareholders
9.19%of listed shares
BlackRock, Inc.4.72M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
BlackRock, Inc. | 9.19%4.72M shares |
DIMENSIONAL FUND ADVISORS LP | 6.00%3.08M shares |
STATE STREET CORP | 5.71%2.93M shares |
AMERICAN CENTURY COMPANIES INC | 5.40%2.77M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 4.29%2.2M shares |
LSV ASSET MANAGEMENT | 3.31%1.7M shares |
ACADIAN ASSET MANAGEMENT LLC | 2.62%1.34M shares |
GEODE CAPITAL MANAGEMENT, LLC | 2.61%1.34M shares |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.34%1.2M shares |
OAK HILL ADVISORS LP | 2.17%1.11M shares |
MILLENNIUM MANAGEMENT LLC | 2.09%1.07M shares |
Ancora Advisors LLC | 2.08%1.07M shares |
AQR CAPITAL MANAGEMENT LLC | 2.03%1.04M shares |
GOLDMAN SACHS GROUP INC | 2.02%1.04M shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 2.01%1.03M shares |
D. E. Shaw & Co., Inc. | 1.75%900.11K shares |
Russell Investments Group, Ltd. | 1.68%859.48K shares |
FEDERATED HERMES, INC. | 1.62%831.13K shares |
PRUDENTIAL FINANCIAL INC | 1.57%805.9K shares |
Prescott Group Capital Management, L.L.C. | 1.51%772.77K shares |
Percentages use 51.3M shares of this listed class outstanding on Jun 30, 2026.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 1, 2026Form 4 · 10b5-1 | Zoon Kathryn CDirector | SellCommon Stock | 1.1K | $8.97 | $9.5K | 79.9K |
| May 1, 2026Form 4 · 10b5-1 | Zoon Kathryn CDirector | SellCommon Stock | 16.1K | $8.36 | $135.0K | 81.0K |
| May 1, 2026Form 4 · 10b5-1 | DeGolyer Donald WDirector | SellCommon Stock | 954 | $8.96 | $8.5K | 129.7K |
| May 1, 2026Form 4 · 10b5-1 | DeGolyer Donald WDirector | SellCommon Stock | 14.5K | $8.36 | $121.4K | 130.7K |
| May 1, 2026Form 4 · 10b5-1 | Dayal Sujata TyagiDirector | SellCommon Stock | 980 | $8.94 | $8.8K | 100.6K |